Nymox Pharmaceutical Corporation (NYMX)
USD 0.2
(-0.05%)
USD 0.2
(-0.05%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 5000.00 | 116 Thousand | 299 Thousand | 224 Thousand |
| Cost of Revenue | - | - | 4000.00 | 58 Thousand | 138 Thousand | 149 Thousand |
| Gross Profit | - | - | 1000.00 | 58 Thousand | 161 Thousand | 75 Thousand |
| Operating Expenses | 6.65 Million | 12.5 Million | 11.72 Million | 13.38 Million | 10.8 Million | 13.31 Million |
| Selling, General and Administrative Expenses | 2.87 Million | 5.84 Million | 3.6 Million | 6 Million | 4.12 Million | 5.43 Million |
| Research and Development Expenses | 3.77 Million | 6.65 Million | 8.12 Million | 7.37 Million | 6.67 Million | 7.87 Million |
| Other Expenses | 113 Thousand | - | - | - | - | - |
| Cost and Expenses | 6.65 Million | 12.5 Million | 11.72 Million | 13.44 Million | 10.94 Million | 13.45 Million |
| Operating Income | -6.65 Million | -12.5 Million | -11.72 Million | -13.32 Million | -10.64 Million | -13.23 Million |
| Interest Expense | 43 Thousand | 39 Thousand | 42 Thousand | 38 Thousand | 18 Thousand | 204 Thousand |
| Income Tax Expense | -5000.00 | 39 Thousand | 42 Thousand | 38 Thousand | -47 Thousand | 204 Thousand |
| Earnings before Tax | -6.57 Million | -12.53 Million | -11.73 Million | -13.16 Million | -10.59 Million | -13.42 Million |
| Net Income | -6.57 Million | -12.57 Million | -11.78 Million | -13.2 Million | -10.59 Million | -13.42 Million |
| Earnings Per Share Basic | -0.07 | -0.15 | -0.16 | -0.19 | -0.18 | -0.26 |
| Earnings Per Share Diluted | -0.07 | -0.15 | -0.16 | -0.19 | -0.18 | -0.26 |
| Weighted Average Shares Outstanding | 89.38 Million | 81.97 Million | 73.82 Million | 68.84 Million | 60.46 Million | 52.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 89.38 Million | 81.97 Million | 73.82 Million | 68.84 Million | 60.46 Million | 52.64 Million |
| Gross Margin | - | - | 0.20 | 0.50 | 0.54 | 0.33 |
| EBIT Margin | - | - | -2285.20 | -108.16 | -35.34 | -59.03 |
| Profit Margin | - | - | -2356.00 | -113.79 | -35.43 | -59.95 |
| EBITDA | -6.28 Million | -12.24 Million | -11.42 Million | -12.54 Million | -10.56 Million | -13.22 Million |
| Earnings Before Tax Margin | - | - | -2344.00 | -114.87 | -35.59 | -59.08 |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 1.1 Million | 1.38 Million | -1.68 Million | 6.65 Million | 1.48 Million | 1.77 Million |
| Selling, General and Administrative Expenses | 506 Thousand | 665 Thousand | 577 Thousand | - | 589 Thousand | 966 Thousand |
| Research and Development Expenses | 594 Thousand | 720 Thousand | -2.26 Million | - | 892 Thousand | 810 Thousand |
| Other Expenses | - | - | -3 Million | 113 Thousand | - | 3.11 Million |
| Cost and Expenses | 1.1 Million | 1.38 Million | -1.68 Million | 6.65 Million | 1.48 Million | 1.77 Million |
| Operating Income | -1.09 Million | -1.38 Million | 1.67 Million | -6.65 Million | -1.47 Million | -1.77 Million |
| Interest Expense | - | 2000.00 | 3.01 Million | 43 Thousand | -10 Thousand | -1000.00 |
| Income Tax Expense | -1000.00 | 2000.00 | 3.14 Million | -5000.00 | 13 Thousand | -3.11 Million |
| Earnings before Tax | -1.11 Million | -1.38 Million | -1.33 Million | -6.57 Million | -1.49 Million | 1.34 Million |
| Net Income | -1.11 Million | -1.38 Million | -4.48 Million | -6.57 Million | -1.5 Million | 4.45 Million |
| Earnings Per Share Basic | -0.01 | -0.02 | -0.05 | - | -0.02 | 0.04 |
| Earnings Per Share Diluted | -0.01 | -0.02 | -0.05 | - | -0.02 | 0.04 |
| Weighted Average Shares Outstanding | 91.26 Million | 90.51 Million | 89.38 Million | 89.38 Million | 91.26 Million | 105.43 Million |
| Weighted Average Shares Outstanding (Diluted) | 91.26 Million | 90.51 Million | 89.38 Million | 89.38 Million | 91.26 Million | 105.43 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.04 Million | -1.32 Million | 1.86 Million | - | -1.42 Million | -1.71 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
BAGFF
COLINZ
OMHI
HEVI
THNOF
002406